Surgical Site Infection Prophylaxis with Cefazolin

Standard Recommended Dosage

The American College of Surgeons recommends a standard dose of 2 g of cefazolin administered 30-60 minutes before surgical incision, with re-dosing of 1 g if the procedure exceeds 4 hours 1, 2, 3

For cardiac surgery, the initial dose is 2 g IV + 1 g in the priming of cardiopulmonary bypass, with re-dosing of 1 g at the 4th hour intraoperatively 1
For neurosurgery (craniotomy, shunt, spinal surgery with prosthetic material), the initial dose is 2 g IV in slow infusion, with re-dosing of 1 g if duration exceeds 4 hours 1
For orthopedic surgery (hip/knee arthroplasty), the initial dose is 2 g IV within 60 minutes before incision, with re-dosing of 1 g if duration exceeds 4 hours 3, 4
The use of cefazolin in orthopedic surgery reduces infection rates from 3-5% to less than 1% 3

The American College of Surgeons recommends that antibiotic prophylaxis be limited to the operative period, with a maximum duration of 24 hours postoperatively 1, 2, 3
Prolonged prophylaxis beyond 24 hours does not provide additional benefit and increases the risk of antibiotic resistance 2

For patients with beta-lactam allergy, vancomycin 30 mg/kg in a 120-minute infusion or clindamycin 900 mg IV in slow infusion can be used as alternatives 1, 3
The infusion of vancomycin should be completed ideally 30 minutes before the start of the procedure 1, 3

For patients with renal insufficiency, dosage adjustments should be made according to creatinine clearance, with a maximum dose of 50% of the usual dose for severe renal insufficiency [[not available due to ignore ref]]
For obese patients, a dose of 2 g of cefazolin may be sufficient for procedures less than 5 hours in duration, but higher doses may be necessary for longer procedures or in cases of super-obesity [[not available due to ignore ref]]

Cefazolin (first generation) is the gold standard for most surgical procedures due to its excellent anti-staphylococcal activity, low cost, and low risk of allergic reactions [[not available due to ignore ref]]
Cefazolin has been shown to be equally effective as ceftriaxone for the prevention of surgical site infections (SSI rates 1.5% vs 1.7% in joint arthroplasty) 4

Cefazolin 2 g IV administered 30–60 minutes before surgical incision is recommended as the first‑line agent; a supplemental dose of 1 g should be given intraoperatively if the procedure exceeds 4 hours. 5, 6

Prophylaxis should be limited to a maximum of 24 hours post‑operatively; extending therapy beyond this period provides no additional benefit and increases the risk of antimicrobial resistance. 5, 7

A systematic review of cardiac and vascular surgery shows that β‑lactam antibiotics with gram‑negative activity reduce postoperative mortality and pneumonia. 6

Routine vancomycin for MRSA prophylaxis is not recommended unless specific high‑risk criteria are met (e.g., documented MRSA colonization, recent antibiotic exposure, re‑operation in a unit with known MRSA prevalence, or a severe β‑lactam allergy). 5
Comparative data indicate no difference in overall surgical‑site infection rates between glycopeptides and β‑lactams in vascular surgery, while glycopeptides are associated with a higher incidence of respiratory tract infections (relative risk ≈ 1.5). 6, 7

The most critical factor for efficacy is timing: the initial dose must be given within 30–60 minutes before incision, with the infusion completed before tourniquet inflation if a tourniquet is used. Starting earlier than 60 minutes offers no added benefit, whereas initiating after incision markedly reduces effectiveness. 8

Third‑generation cephalosporins (e.g., ceftriaxone, cefotaxime) should not be used for routine prophylaxis because they provide no advantage over cefazolin and promote antimicrobial resistance. 5, 7
Vancomycin should not be employed routinely for MRSA coverage in vascular surgery prophylaxis; no MRSA prevalence threshold justifies replacing β‑lactams with glycopeptides. 5, 7